What Is a Macula? Your Eye’s Center of Vision

The macula is a small, specialized area at the center of your retina, the light-sensitive tissue lining the back of your eye. It measures roughly 5.5 to 6 millimeters across, about the size of a pencil eraser, and it’s responsible for the sharp, detailed central vision you use to read, recognize faces, and see color. Without a healthy macula, the center of your visual field becomes blurry, distorted, or blank, even though your peripheral vision may remain intact.

Where the Macula Sits in Your Eye

Light enters through your pupil, passes through the lens, and lands on the retina at the back of the eye. The macula sits right in the middle of that retina, positioned between the main blood vessels that nourish the surrounding tissue. Its full name, macula lutea, means “yellow spot,” and the name is literal. The macula has a yellowish tint caused by a concentration of plant-based pigments called lutein and zeaxanthin, which you absorb from foods like leafy greens and eggs. These pigments act as a natural filter, absorbing damaging blue light before it reaches the delicate cells underneath.

Why the Macula Matters for Vision

Your retina contains two types of light-sensing cells: rods, which handle dim-light and peripheral vision, and cones, which detect color and fine detail. The human eye has about 91 million rods and only 4.5 million cones, and most of those cones are packed into the macula. At the very center of the macula is a tiny pit called the fovea, about 1.2 millimeters wide, where cone density jumps nearly 200-fold compared to the rest of the retina. The innermost 300 micrometers of the fovea, known as the foveola, contains zero rods. It’s exclusively cone territory.

This extreme concentration of cones is what gives you the ability to read fine print, thread a needle, or notice subtle differences in color. Whenever you look directly at something, you’re aiming it at your fovea. Your peripheral retina, dominated by rods, is better at detecting faint light and movement but can’t resolve detail the way the macula can. That’s why you can spot a dim star at the edge of your vision but need to look straight at a street sign to read the words on it.

Zones Within the Macula

The macula isn’t uniform. Eye specialists divide it into concentric zones, each with slightly different cell densities and visual roles. The foveola sits at the very center, less than one degree of your visual angle. Surrounding it is the fovea, then the parafovea (roughly three degrees out), and the perifovea (about six to seven degrees out). Neurons in the foveola respond more slowly than those farther out, which is one reason your eye constantly makes tiny movements: shifting the image across different zones helps your brain process details faster.

What Happens When the Macula Is Damaged

Damage to the macula doesn’t cause total blindness. Instead, it creates a blind or blurry patch right in the center of your vision, called a scotoma. People with macular damage describe objects looking blurred, distorted, or as if they’ve vanished entirely from view. Straight lines may appear wavy. Reading becomes difficult or impossible. You might still see well enough to walk around a room, because your peripheral vision works fine, but the detailed central vision needed for everyday tasks like driving, cooking, or recognizing someone’s face can deteriorate significantly.

Age-Related Macular Degeneration

The most common disease affecting the macula is age-related macular degeneration, or AMD. Globally, about 8 million people had vision impairment from AMD as of 2021, more than double the number in 1990. That figure is projected to climb to roughly 21 million by 2050, with women affected at higher rates than men. A 2025 analysis published in The Lancet found that eliminating tobacco use alone could prevent millions of projected cases.

AMD comes in two forms. Dry AMD, the more common type, develops when tiny yellow protein deposits called drusen accumulate under the macula. Over time, these deposits thin and dry out the tissue. Dry AMD progresses through three stages. In the early stage, drusen are present but vision is still normal. In the intermediate stage, vision may start to look blurry or wavy. Late-stage dry AMD causes noticeable central vision loss. Many people don’t realize they have the condition until it reaches that late stage, which is why routine eye exams matter. Wet AMD is less common but more aggressive. It involves abnormal blood vessels growing beneath the retina and leaking fluid, which can cause rapid vision loss.

Other Macular Conditions

AMD gets the most attention, but other problems can affect the macula too. A macular pucker forms when a thin membrane grows on the retina’s surface and wrinkles it, causing wavy or distorted vision. This usually happens as part of normal aging: the gel that fills your eye (the vitreous) gradually shrinks and pulls away from the retina, and in some people, a scar-like membrane forms during that process. Most macular puckers are mild, but in rare cases they can lead to a macular hole, an actual break in the tissue, or cause significant vision loss.

Macular edema, a buildup of fluid in the macula, can result from diabetes, eye surgery, or inflammatory conditions. The swelling distorts the macula’s tightly organized layers and blurs central vision.

How Doctors Examine the Macula

The primary tool for evaluating the macula is optical coherence tomography, commonly called OCT. It works like an ultrasound but uses light instead of sound waves, producing detailed cross-sectional images of the retina’s layers. The scan is quick, painless, and non-invasive. It lets your eye doctor measure the thickness of the macula down to the micrometer, spot fluid pockets, identify drusen deposits, and track changes over time. A measurement called central subfield thickness, representing the average thickness of the central one millimeter of the macula, is particularly useful for monitoring disease and correlates closely with visual sharpness.

OCT can also reveal subtler signs of damage, such as disruption of specific cell layers in the outer retina. The integrity of certain layers visible on the scan has been linked to better or worse visual outcomes, helping doctors decide when and how aggressively to treat.

Nutrition and Macular Health

The same pigments that give the macula its yellow color, lutein and zeaxanthin, play a protective role. A large clinical trial called AREDS2, run by the National Eye Institute, established a specific supplement formula that slows the progression of intermediate AMD to the advanced stage. The formula includes 10 mg of lutein, 2 mg of zeaxanthin, 500 mg of vitamin C, 400 IU of vitamin E, 80 mg of zinc, and 2 mg of copper (added to prevent a zinc-related copper deficiency). An earlier version of the formula contained beta-carotene instead of lutein and zeaxanthin, but that was dropped because beta-carotene increases lung cancer risk in current and former smokers.

These supplements are not a treatment for everyone. They’re specifically studied in people who already have intermediate AMD in one or both eyes, or advanced AMD in one eye. For people without macular disease, a diet rich in dark leafy greens, colorful fruits, and fish provides the same protective nutrients in smaller, food-based amounts.